» Articles » PMID: 35775038

Treatment Options for Secondary Osteonecrosis of the Knee

Overview
Specialty Orthopedics
Date 2022 Jul 1
PMID 35775038
Authors
Affiliations
Soon will be listed here.
Abstract

Knee osteonecrosis is a debilitating progressive degenerative disease characterized by subchondral bone ischemia. It can lead to localized necrosis, tissue death, and progressive joint destruction. For this reason, it is essential to diagnose and treat this disease early to avoid subchondral collapse, chondral damage, and end-stage osteoarthritis, where the only solution is total knee arthroplasty. Three types of knee osteonecrosis have been documented in the literature: spontaneous or primitive, secondary, and post arthroscopy. Spontaneous osteonecrosis is the most common type studied in the literature. Secondary osteonecrosis of the knee is a rare disease and, unlike the spontaneous one, involves patients younger than 50 years. It presents a particular set of pathological, clinical, imaging, and progression features. The management of secondary osteonecrosis is determined by the stage of the disorder, the clinical manifestation, the size and location of the lesions, whether the involvement is unilateral or bilateral, the patient's age, level of activity, general health, and life expectancy. This review aims to present the recent evidence on treatment options for secondary osteonecrosis of the knee, including conservative treatment, joint preserving surgery, and knee replacement.

Citing Articles

Histopathological evaluation of spontaneous osteonecrosis of the knee: time to reconsider history and nomenclature-a scoping review.

Za P, Ambrosio L, Vasta S, Russo F, Papalia G, Vadala G Musculoskelet Surg. 2024; .

PMID: 39616588 DOI: 10.1007/s12306-024-00874-6.


The efficacy of extracorporeal shock wave therapy for knee osteoarthritis : an umbrella review.

Tang P, Wen T, Lu W, Jin H, Pan L, Li H Int J Surg. 2024; 110(4):2389-2395.

PMID: 38668665 PMC: 11020044. DOI: 10.1097/JS9.0000000000001116.


Bone marrow edema of the knee: a narrative review.

Villari E, Digennaro V, Panciera A, Ferri R, Benvenuti L, Cesare F Arch Orthop Trauma Surg. 2024; 144(5):2305-2316.

PMID: 38642163 PMC: 11093815. DOI: 10.1007/s00402-024-05332-3.

References
1.
Bosco G, Vezzani G, Enten G, Manelli D, Rao N, Camporesi E . Femoral condylar necrosis: treatment with hyperbaric oxygen therapy. Arthroplast Today. 2018; 4(4):510-515. PMC: 6287235. DOI: 10.1016/j.artd.2018.02.010. View

2.
Chang C, Greenspan A, Gershwin M . The pathogenesis, diagnosis and clinical manifestations of steroid-induced osteonecrosis. J Autoimmun. 2020; 110:102460. DOI: 10.1016/j.jaut.2020.102460. View

3.
Myers T, Cui Q, Kuskowski M, Mihalko W, Saleh K . Outcomes of total and unicompartmental knee arthroplasty for secondary and spontaneous osteonecrosis of the knee. J Bone Joint Surg Am. 2006; 88 Suppl 3:76-82. DOI: 10.2106/JBJS.F.00568. View

4.
Parratte S, Argenson J, Dumas J, Aubaniac J . Unicompartmental knee arthroplasty for avascular osteonecrosis. Clin Orthop Relat Res. 2007; 464:37-42. DOI: 10.1097/BLO.0b013e31812f7821. View

5.
Lieberman J, Varthi A, Polkowski 2nd G . Osteonecrosis of the knee - which joint preservation procedures work?. J Arthroplasty. 2013; 29(1):52-6. DOI: 10.1016/j.arth.2013.04.036. View